Table Of ContentIndex
Volume 44 (1-5), 2012
AUTHORS
Agerwala, Suneel M. 44 (4): 307-317. Crévecoeur-MacPhail, Desirée A. 44 (4): 292-298,
al’ Absi, Mustafa 44 (5): 437-440. 299-306.
Albertella, Lucy 44 (5): 381-389. Damle, Uma 44 (5): 398-409.
Alsoofi, Mohammed 44 (5): 437-440. Dawar, Mona 44 (4): 292-298.
Alvarez, Lily 44 (4): 292-298. Denering, Loretta L. 44 (4): 318-324.
Amen, Daniel G. 44 (1): 18-26; (2): 96-106. Dewey, Charlene M. 44 (1): 79-85.
Annibali, Joseph A. 44 (2): 96-106. Dierst-Davies, Rhodri 44 (2): 166-172.
Antonini, Valerie P. 44 (4): 285-291, 292-298, Dokam, Anisa 44 (5): 437-440.
299-306, 325-333. Downs, B. William 44 (5): 398-409.
Arfken, Cynthia L. 44 (5): 428-433. Dunne, Eugene M. 44 (1): 86-91.
Ashley, Larry L. 44 (1): 27-37. DuPont, Robert L. 44 (1): 72-78.
Bailey, John A. 44 (5): 398-409. Eickenhorst, Patrick 44 (5): 418-427.
Baker, John R. 44 (5): 442-445. Essien, E. James 44 (3): 252-258.
Banta-Green, Caleb J. 44 (3): 259-265. Evans, Kristy 44 (3): 224-236.
Barh, Debmalya 44 (2): 134-143; 44 (5): Femino, John 44 (2): 134-143.
398-409. Fernandez, Julia Paige 44 (3): 277-279.
Blum, Kenneth 44 (1): 38-55; (2): 134-143; 44 (5): Fickenscher, Alexandra 44 (2): 153-159.
398-409. Field, Robyn 44 (4): 292-298.
Boehlke, Karmen K. 44 (1): 27-37. Fletcher, Jesse B. 44 (2): 166-172.
Bonnet, Udo 44 (2): 186—190. Fortuna, Jeffrey L. 44 (1): 56-63.
Borsten, Joan 44 (2): 134-143. Frecska, Ede 44 (3): 191-199.
Bowirrat, Abdalla 44 (1): 38-55; (5): 398-409. Freese, Thomas E. 44 (4): 281-284.
Boyd, Misty L. 44 (2): 153-159. Garland, Eric L. 44 (5): 365-371.
Braverman, Eric R. 44 (2): 134-143; 44 (5): 398-409. Ghulyan, Marine 44 (1): 79-85.
Brazeau, James N. 44 (5): 390-397. Giordano, John 44 (1): 38-55; 44 (2): 134-143; 44 (5):
Brotherton, Devan T. 44 (2): 153-159. 398-409.
Brown, Martha E. 44 (1): 79-85. Gold, Mark 44 (1): 38-55.
Brownlee, Keith 44 (5): 390-397. Gonzales, Rachel 44 (4): 342-349.
Bruno, Antonio 44 (5): 359-364. Gray, Jacqueline S. 44 (2): 160-165.
Carnes, Patrick 44 (1): 38—SS. Greenwell, Lisa 44 (4): 342-349.
Carnes, Stefanie 44 (1): 38—55. Groneberg, David 44 (5): 418-427.
Carter, Paula M. 44 (2): 160-165. Gurel, Lee 44 (3): 209-215.
Chalk, Mady 44 (4): 342-349. Halkitis, Perry N. 44 (3): 243-251.
Charania, Mahnaz 44 (5): 351-358. Hanrahan, Michael 44 (3): 259-265.
Chaudhri, Priya 44 (1): 5-17. Harris, Nicholas 44 (5): 390-397.
Chen, Amanda LC. 44 (2): 134-143; 44 (5): 398-409. Harris, Rachel 44 (3): 209-215.
Chen, Thomas JH. 44 (2): 134-143; 44 (5): 398-409. Hartston, Heidi 44 (1): 64-67.
Clarkson, Ashley 44 (5): 390-397. Hauser, Mary 44 (2): 134-143.
Coffin, Phillip O. 44 (3): 259-265. Henderson, Diane McAllister 44 (3): 224-236.
Comtois, Katherine Anne 44 (3): 266-273. Henderson, Theodore 44 (2): 96-106.
Coomes, Curtis M. 44 (5): 351-358. Highum, Diane 44 (2): 96-106.
Cousins, Sarah J.44 (4): 325-333. Howard, Matthew O. 44 (5): 365-371.
Journal of Psychoactive Drugs Volume 44 (5), November—December 2012
Index
Volume 44 (1-5), 2012
AUTHORS
Agerwala, Suneel M. 44 (4): 307-317. Crévecoeur-MacPhail, Desirée A. 44 (4): 292-298,
al’ Absi, Mustafa 44 (5): 437-440. 299-306.
Albertella, Lucy 44 (5): 381-389. Damle, Uma 44 (5): 398-409.
Alsoofi, Mohammed 44 (5): 437-440. Dawar, Mona 44 (4): 292-298.
Alvarez, Lily 44 (4): 292-298. Denering, Loretta L. 44 (4): 318-324.
Amen, Daniel G. 44 (1): 18-26; (2): 96-106. Dewey, Charlene M. 44 (1): 79-85.
Annibali, Joseph A. 44 (2): 96-106. Dierst-Davies, Rhodri 44 (2): 166-172.
Antonini, Valerie P. 44 (4): 285-291, 292-298, Dokam, Anisa 44 (5): 437-440.
299-306, 325-333. Downs, B. William 44 (5): 398-409.
Arfken, Cynthia L. 44 (5): 428-433. Dunne, Eugene M. 44 (1): 86-91.
Ashley, Larry L. 44 (1): 27-37. DuPont, Robert L. 44 (1): 72-78.
Bailey, John A. 44 (5): 398-409. Eickenhorst, Patrick 44 (5): 418-427.
Baker, John R. 44 (5): 442-445. Essien, E. James 44 (3): 252-258.
Banta-Green, Caleb J. 44 (3): 259-265. Evans, Kristy 44 (3): 224-236.
Barh, Debmalya 44 (2): 134-143; 44 (5): Femino, John 44 (2): 134-143.
398-409. Fernandez, Julia Paige 44 (3): 277-279.
Blum, Kenneth 44 (1): 38-55; (2): 134-143; 44 (5): Fickenscher, Alexandra 44 (2): 153-159.
398-409. Field, Robyn 44 (4): 292-298.
Boehlke, Karmen K. 44 (1): 27-37. Fletcher, Jesse B. 44 (2): 166-172.
Bonnet, Udo 44 (2): 186—190. Fortuna, Jeffrey L. 44 (1): 56-63.
Borsten, Joan 44 (2): 134-143. Frecska, Ede 44 (3): 191-199.
Bowirrat, Abdalla 44 (1): 38-55; (5): 398-409. Freese, Thomas E. 44 (4): 281-284.
Boyd, Misty L. 44 (2): 153-159. Garland, Eric L. 44 (5): 365-371.
Braverman, Eric R. 44 (2): 134-143; 44 (5): 398-409. Ghulyan, Marine 44 (1): 79-85.
Brazeau, James N. 44 (5): 390-397. Giordano, John 44 (1): 38-55; 44 (2): 134-143; 44 (5):
Brotherton, Devan T. 44 (2): 153-159. 398-409.
Brown, Martha E. 44 (1): 79-85. Gold, Mark 44 (1): 38-55.
Brownlee, Keith 44 (5): 390-397. Gonzales, Rachel 44 (4): 342-349.
Bruno, Antonio 44 (5): 359-364. Gray, Jacqueline S. 44 (2): 160-165.
Carnes, Patrick 44 (1): 38—SS. Greenwell, Lisa 44 (4): 342-349.
Carnes, Stefanie 44 (1): 38—55. Groneberg, David 44 (5): 418-427.
Carter, Paula M. 44 (2): 160-165. Gurel, Lee 44 (3): 209-215.
Chalk, Mady 44 (4): 342-349. Halkitis, Perry N. 44 (3): 243-251.
Charania, Mahnaz 44 (5): 351-358. Hanrahan, Michael 44 (3): 259-265.
Chaudhri, Priya 44 (1): 5-17. Harris, Nicholas 44 (5): 390-397.
Chen, Amanda LC. 44 (2): 134-143; 44 (5): 398-409. Harris, Rachel 44 (3): 209-215.
Chen, Thomas JH. 44 (2): 134-143; 44 (5): 398-409. Hartston, Heidi 44 (1): 64-67.
Clarkson, Ashley 44 (5): 390-397. Hauser, Mary 44 (2): 134-143.
Coffin, Phillip O. 44 (3): 259-265. Henderson, Diane McAllister 44 (3): 224-236.
Comtois, Katherine Anne 44 (3): 266-273. Henderson, Theodore 44 (2): 96-106.
Coomes, Curtis M. 44 (5): 351-358. Highum, Diane 44 (2): 96-106.
Cousins, Sarah J.44 (4): 325-333. Howard, Matthew O. 44 (5): 365-371.
Journal of Psychoactive Drugs Volume 44 (5), November—December 2012
Volume 44 (2012)
Iguchi, Martin Y. 44 (4): 334-341. Oeser, Brandy T. 44 (4): 285-291, 292-298.
Jefferson, Troy 44 (3): 252-258. Oscar-Berman, Marlene 44 (1): 38—55; 44 (5): 398-409.
Johnson, Regina Jones 44 (3): 252-258. Otto, Michael W. 44 (3): 237-242.
Johnson, Robert 44 (1): 18-26. Owens, Darlene 44 (5): 428-433.
Jones, Hendree E. 44 (5): 351-358. Padwa, Howard 44 (4): 299-306.
Jones, Laura 44 (2): 144-152. Palamar, Joseph J. 44 (3): 243-251.
Jukié, Vlado 44 (2): 173-185. Pandolfo, Gianluca 44 (5): 359-364.
Karim, Reef 44 (1): 5—17. Peavy, K. Michelle 44 (3): 259-265.
Katz, Elizabeth C. 44 (1): 86-91. Peck, James A. 44 (2): 166-172.
Kelder, Steven H. 44 (3): 252-258. Perrine, Kenneth 44 (5): 398-409.
Kerbrat, Amanda H. 44 (3): 266-273. Peters, Jr., Ronald J. 44 (3): 252-258.
Kerner, Mallory 44 (5): 398-409. Pigott, H. Edmund 44 (2): 96-106.
Khalil, Najat Sayem 44 (5): 437-440. Pohl, Mel 44 (2): 119-124.
Kiang, Mathew V. 44 (3): 243-251. Polcin, Douglas L. 44 (2): 144-152; 44 (3): 224-236.
Kingston, Susan 44 (3): 259-265. Pollack, Mark H. 44 (3): 237-242.
Klapp, Burghard F. 44 (5): 418-427. Poulton, Winona E. 44 (5): 351-358.
Korcha, Rachael 44 (3): 224-236. Prickett, James I. 44 (3): 200-208.
Lev-Ran, Shaul 44 (5): 434-436. Prokhorov, Alexander 44 (3): 252-258.
Licata, Robert 44 (2): 96-106. Rawana, Edward P. 44 (5): 390-397.
Liester, Mitchell B. 44 (3): 200-208. Rawson, Richard A. 44 (4): 281-284, 292-298, 299-306,
Lookatch, Samantha J. 44 (1): 86-91. 325-333, 342-349.
Lowe, Jessica M. 44 (3): 266-273. Reback, Cathy J. 44 (2): 166-172.
Lucas, Philippe 44 (2): 125-133. Reilly, Christopher 44 (4): 292-298.
Luna, Luis E. 44 (3): 191-199. Ries, Richard K. 44 (3): 266-273.
Lyvers, Michael 44 (5): 410-417. Romeo, Vincenzo M. 44 (5): 359-364.
Mache, Stefanie 44 (5): 418-427. Roy, A. Kenison 44 (2): 107-118.
Madigan, Margaret A. 44 (5): 398-409. Russo, Joan 44 (3): 266-273.
Manka, Debra 44 (5): 398-409. Rutkowski, Beth A. 44 (4): 281-284.
Manka, Matthew 44 (5): 398-409. Safren, Steven A. 44 (3): 237-242.
Mansergh, Gordon 44 (5): 351-358. Said, Manal 44 (5): 428-433.
Marino, Antonio G. 44 (5): 359-364. Schaper, Elizabeth 44 (4): 292-298.
McCance-Katz, Elinore F. 44 (4): 307-317. Scherbaum, Norbert 44 (2): 186-190.
McDonell, Michael G. 44 (3): 266-273. Scimeca, Giuseppe 44 (5): 359-364.
McHugh, R. Kathryn 44 (3): 237-242. Silverman, Susan 44 (5): 398-409.
Meester, Molly 44 (5): 410-417. Simpatico, Thomas 44 (2): 134-143.
Mento, Carmela 44 (5): 359-364. Skipper, Gregory E. 44 (1): 72-78.
Merrill, Joseph O. 44 (3): 259-265. Smith, David E. 44 (1): 1-4, 68-71; 44 (2): 93-95.
Meshack, Angela 44 (3): 252-258. Smith, Logan 44 (2): 119-124.
Mico Umberto 44 (5): 359-364. Sobiecki, Jean-Francois 44 (3): 216-223.
Miller, David K. 44 (5): 398-409. Somner, Lillian 44 (2): 96-106.
Miller, Merlene 44 (5): 398-409. Spear, Suzanne E. 44 (4): 318-324, 334-341.
Miller, Michael M. 44 (2): 107-118. Spicer, Paul 44 (2): 153-159.
Moore, Laurie 44 (2): 153-159. Stokes, Stan D. 44 (5): 398-409.
Moré, Csaba E. 44 (3): 191-199. Swiggart, William 44 (1): 79-85.
Morse, Siobhan 44 (5): 398-409. Taylor, Derek V. 44 (2): 96-106.
Mulia, Nina 44 (2): 144-152. Teesson, Maree 44 (5): 372-380.
Murray, Heather W. 44 (3): 237-242. Trocki, Karen 44 (3): 224-236.
Muscatello, Maria R.A. 44 (5): 359-364. Trujillo, Manuel 44 (2): 96-106.
Nakajima, Motohiro 44 (5): 437-441. Urada, Darren 44 (4): 285-291, 292-298, 299-306.
Newton, Kathyrn L. 44 (5): 372-380. Vargha, Andras 44 (3): 191-199.
Newton, Nicola C. 44 (5): 372-380. Vitzthum, Karin 44 (5): 418-427.
Norberg, Melissa M. 44 (5): 381-389. Waite, Roger L. 44 (5): 398-409.
Novins, Douglas K. 44 (2): 153-159. Wechsberg, Wendee M. 44 (5): 351-358.
Nuno, Miriam 44 (2): 166-172. Weitzman, Meara 44 (3): 237-242.
Ober, Allison 44 (4): 299-306. Werner, Tonia 44 (1): 38-55.
Journal of Psychoactive Drugs Volume 44 (5), November—December 2012
Volume 44 (2012)
Whitt, Ahmed 44 (5): 365-371. BRAIN SPECT SCANS
Wilcox, James 44 (3): 274-276. The clinical utility of brain SPECT imaging in process
Willeumier, Kristen 44 (1): 18-26; 44 (2): 96-106. addictions. Amen, D.G.; Willeumier, K. & Johnson, R. 44
Wittman, Fried 44 (3): 224-236. (1): 18-26.
Zimié, Jadranka Ivandié 44 (2): 173-185. Specific ways brain SPECT imaging enhances clinical psy-
Zoccali, Rocco 44 (5): 359-364. chiatric practice. Amen, D.G.; Highum, D.; Licata, R.;
Zule, William A 44 (5): 351-358. Annibali, J.A.; Somner, L.; Pigott, H.E.; Taylor, D.V.;
Trujillo, M.; Newberg, A.; Henderson, T. & Willeumier, K.
44 (2): 96-106.
ADOLESCENTS AND EMERGING ADULTS CATHINONE AND KHAT
Adolescents’ experiences of a strengths-based treatment A case of treating cathinone dependence and comorbid
program for substance abuse. Harris, N.; Brazeau, J.N.; depression using bupropion. Lev-Ran, S. 44 (5): 434-436.
Clarkson, A.; Brownlee, K. & Rawana, E.P. 44 (5): 390-397. An examination of the Fagerstrém Test for nicotine depen-
Familial risk factors favoring drug addiction onset. Zimic, dence among concurrent tobacco and khat users. Nakajima,
J.1. & Jukié, V. 44 (2): 173-185. M.; al’ Absi, M.; Dokam, A.; Alsoofi, M. & Khalil, N.S. 44
Mental health symptoms and their relationship to (5): 437-441.
cannabis use in adolescents attending residential treatment.
Albertella, L. & Norberg, M.M. 44 (5): 381-389. CHRONIC PAIN
Predictors of stigmatization towards use of various illicit Cannabis as an adjunct to or substitute for opiates in the
drugs among emerging adults. Palamar, J.J.; Kiang, M.V. treatment of chronic pain. Lucas, P. 44 (2): 125-133.
& Halkitis, P.N. 44 (3): 243-251. Chronic pain and addiction: Challenging co-occurring dis-
orders. Pohl, M. & Smith, L. 44 (2): 119-124.
ALCOHOL
Intercepting binge drinkers in medical settings: A view CO-OCCURRING DISORDER QUADRANT
from California. Spear, S.E. & Iguchi, M.Y. 44 (4): 334— MODEL
341. Validation of the Co-occurring Disorder Quadrant Model.
McDonell, M.G.; Kerbrat, A.H. ; Comtois, K.A.; Russo, J.;
ALPHA-METHYLTRYPTAMINE Lowe, J.M. & Ries, R.K. 44 (3): 266-273.
Psychoactive properties of alpha-methyltryptamine:
Analysis from self reports of users. Wilcox, J. 44 (3): CRIMINAL JUSTICE
274-276. Racial and ethnic differences in reported criminal justice
referral at treatment admission. Arfken, C.L.; Said, M. &
AYAHUASCA Owens, D. 44 (5): 428-433.
Enhancement of creative expression and entoptic phenom-
ena as after-effects of repeated ayahuasca ceremonies. DOPAMINE AND REWARD GENE
Frecska, E.; Moré, C.E.; Vargha, A. & Luna, L.E. 44 (3): POLYMORPHISMS
191-199. The addictive brain: All roads lead to dopamine. Blum,
Hypotheses regarding the mechanisms of ayahuasca in the K.; Chen, A.LC .; Giordano, J.; Borsten, J.; Chen, T.JH.;
treatment of addictions. Liester, M.B. & Prickett, J.I. 44 Hauser, M.; Simpatico, T.; Femino, J.; Braverman, E.R. &
(3): 200-208. Barh, D. 44 (2): 134-143.
A study of ayahuasca use in North America. Harris, R. & Early intervention of intravenous KB220IV- neuroadapta-
Gurel, L. 44 (3): 209-215. gen amino-acid therapy (NAAT)™ improves behavioral
outcomes in a residential addiction treatment program:
BOOK REVIEW A pilot study. Miller, M.; Chen, A.LC.; Stokes, S.D. ;
Labate, Beatriz Caiuby & Henrik Jungaberle (Eds.) The Silverman, S.; Bowirrat, A.; Manka, M.; Manka, D.; Miller,
Internationalization of Ayahuasca. Reviewed by Baker, D.K.; Perrine, K. ; Chen, T.JH. ; Bailey, J.A.; Downs, B.W.;
J.R. 44 (5): 442-445. Waite, R.L.; Madigan, M.A.; Braverman, E.R. ; Damle, U.;
Kerner, M.; Giordano, J.; Morse, S.; Oscar-Berman, M..;
CANNABIS Barh, D. & Blum, K. 44 (5): 398-409.
Cannabis as an adjunct to or substitute for opiates in the Sex, drugs, and rock ‘n’ roll: Hypothesizing common
treatment of chronic pain. Lucas, P. 44 (2): 125-133. mesolimbic activation as a function of reward gene
Mental health symptoms and their relationship to polymorphisms. Blum, K.; Werner, T.; Carnes, S.; Carnes,
cannabis use in adolescents attending residential treatment. P.; Bowirrat, A.; Giordano, J.; Oscar-Berman, M. & Gold,
Albertella, L. & Norberg, M.M. 44 (5): 381-389. M. 44 (1): 38-55.
Journal of Psychoactive Drugs Volume 44 (5), November—December 2012
Index Volume 44 (2012)
ECSTASY (MDMA) homeless, substance-dependent MSM. Reback, C.J.; Peck,
Developing the Climate Schools: Ecstasy Module—A uni- J.A.; Fletcher, J.B.; Nuno, M. & Dierst-Davies, R. 44 (2):
versal Internet-based drug prevention program. Newton, 166-172.
N.C.; Teesson, M. & Newton, K.L. 44 (5): 372-380. Results of a pilot study to reduce methamphetamine use
Illicit use of LSD or psilocybin, but not MDMA or and sexual risk behaviors among methamphetamine-using
nonpsychedelic drugs, is associated with mystical experi- men who have sex with men (MSM) not currently in
ences in a dose-dependent manner. Lyvers, M. & Meester, treatment. Zule, W.A.; Poulton, W.E.; Coomes, C.M.;
M. 44 (5): 410-417. Mansergh, G.; Charania, M.; Wechsberg, W.M. & Jones,
H.E. 44 (5): 351-358.
FOOD ADDICTION
The obesity epidemic and food addiction. Clinical similar- METHAMPHETAMINE
ities to drug dependence. Fortuna, J.L. 44 (1): 56-63. Process-of-care measures as predictors of client out-
come among a methamphetamine-dependent sample at |2-
GAMBLING and 36-month follow-ups. Rawson, R.A.; Gonzales, R.;
Pathological gambling: A general overview. Ashley, L.L. & Greenwell, L. & Chalk, M. 44 (4): 342-349.
Boehlke, K.K. 44 (1): 27-37. Results of a pilot study to reduce methamphetamine use
and sexual risk behaviors among methamphetamine-using
HEALTH CARE REFORM men who have sex with men (MSM) not currently in
Editor’s note: The medicalization of therapeutic communi- treatment. Zule, W.A.; Poulton, W.E.; Coomes, C.M.;
ties in the era of health care reform. Smith, D.E. 44 (2): Mansergh, G.; Charania, M.; Wechsberg, W.M. & Jones,
93-95. H.E. 44 (5): 351-358.
The medicalization of addiction treatment professionals.
Roy, A.K. & Miller, M.M. 44 (2): 107-118. NATIVE AMERICANS
Growing our own: Building a native research team. Gray,
HELIUM J.S. & Carter, P.M. 44 (2): 160-165.
Helium inhalation in adolescents: Characteristics of users Walking On: Celebrating the journeys of Native American
and prevalence of use. Whitt, A.; Garland, E.L. & Howard, adolescents with substance use problems on the winding
M.O. 44 (5): 365-371. road to healing. Novins, D.K.; Boyd, M.L.; Brotherton,
D.T.; Fickenscher, A.; Moore, L. & Spicer, P. 44 (2):
INTEGRATED CARE 153-159.
The California Integration Learning Collaborative: A
forum to address challenges of SUD-primary care service NEUROENHANCEMENT
integration. Antonini, V.P.; Oeser, B.T. & Urada, D. 44 (4): Neuroenhancement among German university students:
285-291. Motives, expectations, and relationship with psychoactive
Editors’ introduction: The evidence for integrated care— lifestyle drugs. Eickenhorst, P.; Vitzthum, K.; Klapp, B.F.;
substance use disorders, mental health, and primary care: Groneberg, D. & Mache, S. 44 (5): 418-427.
California Substance Abuse Research Consortium (SARC)
Meetings, 2011. Rutkowski, B.A.; Rawson, R.A. & Freese, OPIOIDS
T.E. 44 (4): 281-284. “Hooked on” prescription-type opiates prior to using
Integrating substance use disorder services with primary heroin: Results from a survey of syringe exchange clients.
care: The experience in California. Padwa, H.; Urada, D.; Peavy, K.M.; Banta-Green, C.J.; Kingston, S.; Hanrahan,
Antonini, V.P.; Ober, A.; Crévecoeur-MacPhail, D.A. & M.; Merrill, J.O. & Coffin, P.O. 44 (3): 259-265.
Rawson, R.A. 44 (4): 299-306. Sexual HIV risk behaviors in a treatment-refractory opioid-
Perceptions of mental health and substance use disor- dependent sample. McHugh, R.K.; Weitzman, M.; Safren,
der services integration among the workforce in pri- S.A.; Murray, H.W.; Pollack, M.H. & Otto, M.W. 44 (3):
mary care settings. Urada, D.; Schaper, E.; Alvarez, L. ; 237-242.
Reilly, C. ; Dawar, M.; Field, R.; Antonini, V.P.; Oeser,
B.T.; Crévecoeur-MacPhail, D.A. & Rawson, R.A. 44 (4): PHYSICIAN HEALTH PROGRAMS
292-298. Six lessons from state physician health programs to pro-
Utilization, measurement, and funding of recovery supports mote long-term recovery. DuPont, R.L. & Skipper, G.E. 44
and services. Cousins, S.J.; (1): 72-78.
MEN WHO HAVE SEX WITH MEN (MSM) PRESCRIPTION DRUGS
Lifetime substance use and HIV sexual risk behaviors pre- “Hooked on” prescription-type opiates prior to using
dict treatment response to contingency management among heroin: Results from a survey of syringe exchange clients.
Journal of Psychoactive Drugs Volume 44 (5), November—December 2012
Volume 44 (2012)
Peavy, K.M.; Banta-Green, C.J.; Kingston, S.; Hanrahan, RECOVERY
M.; Merrill, J.O. & Coffin, P.O. 44 (3): 259-265. Perceptions of sober living houses among addiction coun-
Predictors of nonmedical use of prescription stimulants. selors and mental health therapists: Knowledge, views and
Lookatch, S.J.; Dunne, E.M. & Katz, E.C. 44 (1): 86-91. perceived barriers. Polcin, D.L.; Henderson, D.M.; Korcha,
Prescribing practices and the prescription drug epidemic: R.; Evans, K.; Wittman, F. & Trocki, K. 44 (3): 224-236.
Physician intervention strategies. Smith, D.E. 44 (1): 68- Substance users’ perspectives on helpful and unhelpful
71. confrontation: Implications for recovery. Polcin, D.; Mulia,
Searching for answers: Proper prescribing of controlled N. & Jones, L. 44 (2): 144-152.
prescription drugs. Brown, M.E.; Swiggart, W.; Dewey,
C.M. & Ghulyan, M. 44 (1): 79-85. SBIRT
Integrating screening, brief intervention, and referral to
PROCESS ADDICTIONS treatment (SBIRT) into clinical practice settings: A brief
Behavioral addictions: An overview. Karim, R. & review. Agerwala, S.M. & McCance-Katz, E.F. 44 (4):
Chaudhri, P. 44 (1): 5-17. 307-317.
The case for compulsive shopping as an addiction. Routine use of screening and brief intervention for college
Hartston, H. 44 (1): 64-67. students in a university counseling center. Denering, L.L.
The clinical utility of brain SPECT imaging in process & Spear, S.E. 44 (4): 318-324.
addictions. Amen, D.G.; Willeumier, K. & Johnson, R. 44
(1): 18-26. SEX
Editor’s note: The process addictions and the new ASAM Drugs and sexual behavior. Bruno, A.; Scimeca, G.; Marino,
definition of addiction. Smith, D.E. 44 (1): 1-4. A.G.; Mento, C.; Micd U.; Romeo, V.M.; Pandolfo, G.;
The obesity epidemic and food addiction. Clinical similar- Zoccali, R. & Muscatello, M.R.A. 44 (5): 359-364.
ities to drug dependence. Fortuna, J.L. 44 (1): 56-63. Sex, drugs, and rock ‘n’ roll: Hypothesizing common
Pathological gambling: A general overview. Ashley, L.L. & mesolimbic activation as a function of reward gene
Boehlke, K.K. 44 (1): 27-37. polymorphisms. Blum, K.; Werner, T.; Carnes, S.; Carnes,
P.; Bowirrat, A.; Giordano, J.; Oscar-Berman, M. & Gold,
PROPOFOL M. 44 (1): 38-55.
Craving dominates propofol addiction of an affected physi- Sexual HIV risk behaviors in a treatment-refractory opioid-
cian. Bonnet, U. & Scherbaum, N. 44 (2): 186-190. dependent sample. McHugh, R.K.; Weitzman, M.; Safren,
S.A.; Murray, H.W.; Pollack, M.H. & Otto, M.W. 44 (3):
PROPY LHEXEDRINE 237-242.
Propylhexedrine: A vintage drug of abuse, rediscovered.
Fernandez, J.P. & Francis, E.M. 44 (3): 277-279. TOBACCO
Cigarette smoking topography among alternative school
PSYCHOACTIVE DRUGS youth: Why African American youth smoke less but are
Illicit use of LSD or psilocybin, but not MDMA or at higher long-term risk. Peters, Jr., R.J.; Kelder, S.H.;
nonpsychedelic drugs, is associated with mystical experi- Johnson, R.J.; Prokhorov, A.; Meshack, A.; Jefferson, T.
ences in a dose-dependent manner. Lyvers, M. & Meester, & Essien, E.J. 44 (3): 252-258.
M. 44 (5): 410-417. An examination of the Fagerstrém Test for nicotine depen-
Psychoactive Ubulawu spiritual medicines and healing dence among concurrent tobacco and khat users. Nakajima,
dynamics in the initiation process of Southern Bantu divin- M.; al’Absi, M.; Dokam, A.; Alsoofi, M. & Khalil, N.S. 44
ers. Sobiecki, J-F. 44 (3): 216-223. (5): 437-441.
Journal of Psychoactive Drugs Volume 44 (5), November—December 2012
